Cargando…
Real-Life Experience of the Prognostic Significance of the Primary Tumor Location on the Timing of Colorectal Liver Metastases: A Retrospective Analysis
Background Numerous research studies have looked into how the primary tumor location (PTL) affects patients’ prognosis for colorectal cancer (CRC). Our research aimed to investigate the prognostic effects of PTL in patients with synchronous (SM) and metachronous (MM) colorectal cancer liver metastas...
Autores principales: | Signorelli, Carlo, Amodio, Pietro Maria, Chilelli, Mario Giovanni, Santoro, Roberto, Schirripa, Marta, Ranalli, Teresa Valentina, Pessina, Gloria, Giron Berrios, Julio Rodrigo, Natoni, Federica, Virtuoso, Antonella, Primi, Francesca, Mazzotta, Marco, Nelli, Fabrizio, Fabbri, Agnese, Marrucci, Eleonora, Ruggeri, Enzo Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588390/ https://www.ncbi.nlm.nih.gov/pubmed/36299600 http://dx.doi.org/10.7759/cureus.30607 |
Ejemplares similares
-
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study
por: Nelli, Fabrizio, et al.
Publicado: (2023) -
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study
por: Nelli, Fabrizio, et al.
Publicado: (2022) -
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients
por: Ruggeri, Enzo Maria, et al.
Publicado: (2022) -
Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study
por: Ruggeri, E.M., et al.
Publicado: (2021) -
Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study
por: Nelli, F., et al.
Publicado: (2022)